ArticleTranslational cancer research2025

Novel combinations with programmed cell death 1 inhibitor for incurable recurrent/metastatic head and neck squamous cell carcinoma (RM HNSCC): is cabozantinib a front runner?

Priyanka Bhateja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.